Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › MAP2K1 (MEK1) as a therapeutic target for arteriovenous malformations and associated disorders

MAP2K1 (MEK1) as a therapeutic target for arteriovenous malformations and associated disorders

US Patent 11104955 · Granted Aug 31, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for low frequency somatic cell mutation identification and quantification2024
Method for inducing a multiclade immune response against HIV utilizing a multige2013
HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HI2012
HIV vaccines based on Env of multiple clades of HIV2011
HIV vaccines based on Env of multiple clades of HIV2010
Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immun2008
Assays for assembly of Ebola virus nucleocapsids2008
Methods and apparatus for spinning spider silk protein2006
Aspergillus niger beta-galactosidase gene1998